-
CAR–T FDA Trial Approval
This was especially exciting news to me. I feel like a number of my symptoms are due to inflammation and a potential therapy that targets inflammation seems like just what I might need. I’ll be keeping an eye on this.
multiplesclerosisnewstoday.com
Iaso Bio's CAR T-cell therapy cleared by FDA for testing in MS
Iaso Bio has received clearance from the FDA to start clinical trials to test its CAR T-cell therapy equecabtagene autoleucel in MS patients.
-
0 Replies
Sorry, there were no replies found.
Log in to reply.